GILEAD SCIENCES, INC. 4

Gilead Sciences Chairman & CEO Daniel Patrick O'Day had 8,780 RSUs vest into common stock and 4,230 shares withheld for taxes.

On September 10, 2026, Gilead Sciences, Inc. Chairman & CEO Daniel Patrick O'Day had 8,780 restricted stock units vest and convert into an equivalent number of common shares, increasing his directly owned common stock to 585,913 shares. In connection with this vesting, 4,230 of the newly issued shares were immediately withheld at a price of $144.81 per share to satisfy tax withholding obligations, reducing his post-withholding direct common stock holdings to 581,683 shares and reflecting a routine equity compensation event rather than an open-market purchase or discretionary sale.

Filing Facts

CIK

882095

Ticker

GILD

Form

4

Source Type

fda

Accession

0001638643-26-000033

Alert Tier

7